Literature DB >> 3821935

Interactions of morphine with apomorphine: behavioural and biochemical studies.

H G Möller, K Kuschinsky.   

Abstract

The interactions of morphine with the agonist at dopamine receptors apomorphine were studied on the behavioural and biochemical level. Apomorphine (0.5 mg/kg s.c.) produced stereotyped sniffing and some licking behaviour. Pretreatment with morphine enhanced licking behaviour and, in addition, produced some gnawing behaviour, a sign which is seen after a larger dose of apomorphine alone as well. This enhancement by morphine was maximal after 3.3 mg/kg i.p. and less pronounced after smaller or larger doses of morphine; naloxone (1 mg/kg i.p.) antagonized the enhancement. Morphine did not affect the decrease in the concentration of 3,4-dihydroxyphenylacetic acid (DOPAC) produced by apomorphine in striatum and nucleus accumbens. In contrast, morphine increased the concentration of 3-methoxytyramine (3-MT) in both areas after pretreatment with pargyline (75 mg/kg i.p.), suggesting that it increased the release of dopamine, which might explain the enhancement of apomorphine-induced stereotyped behaviour. The enhancement by morphine of stereotyped behaviour produced by lisuride (2 or 4 mg/kg i.p.), another agonist at dopamine receptors, was much less pronounced than on apomorphine-induced stereotypies.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3821935     DOI: 10.1007/bf00569385

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  21 in total

1.  Neurochemical aspects of the opioid-induced 'catatonia'.

Authors:  U Havemann; K Kuschinsky
Journal:  Neurochem Int       Date:  1982       Impact factor: 3.921

2.  The role of telencephalic dopaminergic systems in the mediation of apomorphine-stereotyped behaviour.

Authors:  B Costall; R J Naylor
Journal:  Eur J Pharmacol       Date:  1973-10       Impact factor: 4.432

3.  3-Methoxytyramine: its suitability as an indicator of synaptic dopamine release.

Authors:  P C Waldmeier; J Lauber; W Blum; W J Richter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-01       Impact factor: 3.000

4.  Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390.

Authors:  A G Molloy; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  Increased sensitivity to dopamine agonists following a single dose of morphine or levorphanol in mice.

Authors:  J R Martin; A E Takemori
Journal:  Eur J Pharmacol       Date:  1985-12-10       Impact factor: 4.432

6.  Turnover of acid dopamine metabolites in striatal and mesolimbic tissue of the rat brain.

Authors:  B H Westerink; J Korf
Journal:  Eur J Pharmacol       Date:  1976-06       Impact factor: 4.432

7.  3-Methoxytyramine as an indicator of impulse-induced dopamine release in rat brain in vivo.

Authors:  W Kehr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-06       Impact factor: 3.000

8.  Sequence and significance of dopamine metabolism in the rat brain.

Authors:  B H Westerink
Journal:  Neurochem Int       Date:  1985       Impact factor: 3.921

9.  In vivo electrochemical studies of rat striatal dopamine and serotonin release after morphine.

Authors:  P A Broderick
Journal:  Life Sci       Date:  1985-06-17       Impact factor: 5.037

10.  Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum.

Authors:  P H Kelly; P W Seviour; S D Iversen
Journal:  Brain Res       Date:  1975-09-05       Impact factor: 3.252

View more
  4 in total

1.  Conditioning of behavioural signs produced by nomifensine and by B-HT 920 in rats.

Authors:  K Nowak; H G Möller; K Kuschinsky
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

2.  Effects of morphine on EEG in rats and their possible relations to hypo- and hyperkinesia.

Authors:  B Ferger; K Kuschinsky
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

3.  Conditioned tolerance to haloperidol- and droperidol-induced catalepsy.

Authors:  K Nowak; S Welsch-Kunze; K Kuschinsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-04       Impact factor: 3.000

4.  Role of dopamine receptors in the dual effect of naloxone on quinpirole-induced yawning in morphine pretreated rats.

Authors:  A Zharkovsky; J Moisio; T Kivastik; L Ahtee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.